IQVIA Report Discusses Using RWD to Understand the Burden of Cancer as Yearly Spending Hits $157 Billion
IQVIA’s Dr. Chi-Chang Chen discusses the far-reaching impact of cancer care. Last year, approximately $157 billion was spent on cancer [...]
Seminar with Adrian Towse from Office of Health economics in London | Bi
Register England is at the forefront of health economic science. BI Norwegian Business School has invited professor emeritus Adrian Towse [...]
Which Is A Goal Of Meaningful Use Stage 3
Which Is A Goal Of Meaningful Use Stage 3 July 31, 2021 Post a Comment Meaningful Use Health Outcome Priorities [...]
JAMA Study Uses Population Health Data to Understand the Economic Impact of COVID-19
Researchers in Australia sought to understand the impact of COVID-19 using population health data. The article, published in the Journal [...]
Global consulting firm ZS appoints Pratap Khedkar as CEO
Global consulting firm ZS appoints Pratap Khedkar as CEO Global consulting and technology firm ZS has named two-decade company veteran [...]
Radicle Science Launches Largest Longitudinal Real World Evidence Study to Determine Effectiveness of CBD Products
[Business Wire] Radicle Science Launches Largest Longitudinal Real World Evidence Study to Determine Effectiveness of CBD Products The nearly 3,000 [...]
ReWalk Robotics Appoints Jeannine Lynch as Vice President of Strategy and Market Access
MARLBOROUGH, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK), a manufacturer of robotic medical devices for [...]
Study Highlights Use of RWD and Data Analytics to Identify High-Risk Prostate Cancer Patients
Researchers at the University of Michigan used real world data (RWD) and data analytics to determine which prostate cancer patients [...]
Guidance: Health economics: a guide for public health teams
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public [...]
ICER’s Final Evidence Report on Biogen’s Aduhelm Released, Notes Insufficient Clinical Evidence for Overly Expensive Alzheimer’s Drug
The Institute for Clinical and Economic Review (ICER) has published its Final Evidence Report on aducanumab, Biogen’s infamous Alzheimer’s drug. [...]
Building Healthcare Consumers’ Trust in Personalized Digital and Data-Led Services
In most areas of our lives today, consumer power and the capabilities of modern information technologies means organizations that serve [...]
Sensyne grows medical research dataset to 60 million patients
TMCnet News |[August 02, 2021]| Sensyne grows medical research dataset to 60 million patients Sensyne Health plc (LSE: SENS) ("Sensyne" [...]
Certara’s BaseCase Data Connect Solution Seamlessly Automates Data Updates
Keeping up the most recent data can be challenging and needlessly time-consuming. Certara’s secure BaseCase Data Connect solution promises a [...]
PhRMA President and CEO Discusses Lowering Prescription Drug Prices Using Patient-Centered Medicare Legislation
PhRMA CEO and President Stephen Ubl discusses how new Medicare legislation could impact consumers at a time when patients continue [...]
OPEN Health Announces Acquisition of Medical Communications Company Spirit
OPEN Health will acquire medical communications group Spirit. The acquisition is expected to improve OPEN Health’s offerings for its medical [...]
MedTech Innovation Company Veranex Acquires Experien Group for Undisclosed Sum
Veranex is acquiring Experien Group to provide comprehensive consulting services to medtech companies. This move is expected to bolster Veranex’s [...]
Amazon Launches AWS for Health, Joins Google Cloud and Microsoft Cloud for Healthcare in Effort to Streamline Drug Development
Amazon is the latest company to enter the cloud-based healthcare space. It recently launched Amazon Web Services (AWS) for Health. [...]
ICER Announces Positive Early Results in Draft Evidence Report for Two Myasthenia Graves Therapies
The Institute for Clinical and Economic Review (ICER) has published its Draft Evidence Report on two drugs, eculizumaband efgartigimod, used [...]
Costly Oncology Drugs Face ICER Scrutiny and Calls for Value-Based Pricing
Novel drugs used in cancer treatment, including chimeric antigen receptor (CAR)-T cell therapies, are increasing in popularity. However, their cost [...]
Patient Advocacy Organizations (PAOs) Thrilled With Biogen’s Aduhelm Approval As Northeastern and Yale Experts Call for Revised Scope of PAOs
Patient advocacy groups (PAOs) look to drugs receiving accelerated approval from the Food and Drug Administration, such as the contentious [...]
ISPOR Article Highlights Substantial Yet Forgotten Impact of Healthcare on Patient Caregivers
An article published in the May/June issue of ISPOR’s Value & Outcomes Spotlight highlights the burden of disease on patient [...]
Role of Information Technology in the Pharmaceutical Industry
Information Technology has played a huge role in advancing the pharmaceutical industry. Discover the benefits offered by IT in the [...]
ISPOR’s Value & Outcomes Spotlight Features Visual Representation Detailing How HEOR Impacts Healthcare Policy and Decision-Making
An article in ISPOR’s May/June issue of its Value & Outcomes Spotlight magazine visually details how health economics and outcomes [...]
New ISPOR Article Highlights Need for Clearly Defining Fit-For-Purpose RWD in Oncology Research, Reveals UReQA RWD Selection Framework
Fit-for-purpose real world data (RWD) is an attractive source of decision-making data. Multiple stakeholders, including regulatory affairs professionals and payers, [...]
ISMPP Seeks Educational Content Manager – Apply Today!
The International Society for Medical Publication Professionals (ISMPP) is seeking an Educational Content Manager to create and deliver ISMPP communications. [...]